Search Results - "McCallum, H.M."

Evaluation of MRI Distortion Correction for Use in Radiotherapy Treatment Planning by Harron, E.C, Firbank, M.J, McKenna, J, McCallum, H.M, Mohanraj, R

Get full text

PO-1935: MR-only prostate radiotherapy – how transferable are CT based image matching skills? by Brooks, R., McCallum, H.M., Pilling, K., Pearson, R.A., Wyatt, J.J.

Get full text

OC-0473: Evaluation of first 20 patients treated with MR-Only prostate radiotherapy with MR-CBCT matching by Wyatt, J., Pearson, R.A., Frew, J., Walker, C., Richmond, N., Wilkinson, M., Wilkes, K., Driver, S., West, S., Pilling, K., Brooks, R.L., Ainslie, D., Wilkins, E., McCallum, H.M.

Get full text

The first patients treated with MR-CBCT soft-tissue matching in a MR-only prostate radiotherapy pathway by Wyatt, J.J., Pearson, R.A., Frew, J., Walker, C., Richmond, N., Wilkinson, M., Wilkes, K., Driver, S., West, S., Karen, P., Brooks-Pearson, R.L., Ainslie, D., Wilkins, E., McCallum, H.M.

“…Magnetic Resonance (MR)-only radiotherapy for prostate cancer has previously been reported using fiducial markers for on-treatment verification. MR-Cone Beam…”
Get full text

Co-amplification of erbB2, topoisomerase II alpha and retinoic acid receptor alpha genes in breast cancer and allelic loss at topoisomerase I on chromosome 20 by Keith, W N, Douglas, F, Wishart, G C, McCallum, H M, George, W D, Kaye, S B, Brown, R

“…The DNA topoisomerase enzymes are targets for the cytotoxic effects of a number of anticancer agents termed topoisomerase inhibitors. We have analysed breast…”
Get more information

Occult primary seminoma: eighteen-year delay in presentation by Lewi, H J, Walker, L, Gharmool, B E, McCallum, H M, Hutchison, A G

“…Primary retroperitoneal seminoma is well documented. A case is reported in which a patient presented with a seminoma of testis eighteen years after removal of…”
Get more information